Late breaking abstracts – FLAURA study
The final analyses of two key trials – Checkmate 227, part 1 and FLAURA should help to position nivolumab + ipilimumab combination treatment and to reinforce osimertinib as… read more.
The final analyses of two key trials – Checkmate 227, part 1 and FLAURA should help to position nivolumab + ipilimumab combination treatment and to reinforce osimertinib as… read more.
For the second time this year, LungCancer.Med headed to Barcelona for the Annual European Society for Medical Oncology (ESMO) meeting. Written by Christine Clark
Researchers find that several genetic disorders, including MUC1 kidney disease, may share a novel molecular mechanism — and identify a promising therapeutic lead. Misfolded MUC1-fs protein (green) builds up in the kidneys of a mouse model of MUC1 kidney disease.
Includes education and counselling component for caregivers American Academy of Otolaryngology – Head and Neck Surgery
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder affecting 10 – 20 per cent of people. Abdominal pain, bloating and altered bowel habit significantly affect patients’ quality… read more.
Two years after recommendations, only a small percentage have been tested. A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus… read more.
The result opens new avenues for the treatment of disorders such as ulcerative colitis or Crohn’s disease.
Acinic cell carcinoma is the third most common malignant form of salivary gland cancer.
A new study from St. Michael’s Hospital in Toronto, Canada shed lights on how a class of medications that help regulate blood sugar for patients with Type 2… read more.
The European Society of Cardiology (ESC) Guidelines on diabetes, pre-diabetes and cardiovascular diseases are published online in European Heart Journal,(1) and on the ESC website.(2) They were developed in… read more.
University of Queensland scientists have identified a way to help dermatologists determine a patient’s risk of developing melanoma.
Not all fats are equal in how they affect our skin, according to a new study in the Journal of Investigative Dermatology
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.